Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction.
Ulander L, Simonen P, Tolppanen H, Hartman O, Rissanen TT, Eklund KK, Kalaoja M, Kurkela M, Neuvonen M, Niemi M, Backman JT, Gylling H, Sinisalo J; OXI pilot trial. Ulander L, et al. Among authors: tolppanen h. Atheroscler Plus. 2023 Jun 26;53:26-32. doi: 10.1016/j.athplu.2023.06.003. eCollection 2023 Sep. Atheroscler Plus. 2023. PMID: 37448694 Free PMC article.
Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial.
Ulander L, Tolppanen H, Hartman O, Rissanen TT, Paakkanen R, Kuusisto J, Anttonen O, Nieminen T, Yrjölä J, Ryysy R, Drews T, Utriainen S, Karjalainen P, Anttila I, Nurmi K, Silventoinen K, Koskinen M, Kovanen PT, Lehtonen J, Eklund KK, Sinisalo J. Ulander L, et al. Among authors: tolppanen h. Int J Cardiol. 2021 Aug 15;337:21-27. doi: 10.1016/j.ijcard.2021.04.062. Epub 2021 May 4. Int J Cardiol. 2021. PMID: 33961943 Free article. Clinical Trial.
24-hour ambulatory blood pressure and cryptogenic ischemic stroke in young adults.
Tulkki L, Martinez-Majander N, Haapalahti P, Tolppanen H, Sinisalo J, Repo O, Sarkanen T, Numminen H, Ryödi E, Ylikotila P, Roine RO, Lautamäki R, Saraste A, Miettinen T, Autere J, Jäkälä P, Hedman M, Huhtakangas J, Junttola U, Putaala J, Pirinen J; SECRETO Study Group. Tulkki L, et al. Among authors: tolppanen h. Ann Med. 2023 Dec;55(1):2203513. doi: 10.1080/07853890.2023.2203513. Ann Med. 2023. PMID: 37086083 Free PMC article.
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock.
Jäntti T, Tarvasmäki T, Harjola VP, Pulkki K, Turkia H, Sabell T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, DiSomma S, Mebazaa A, Haapio M, Lassus J; CardShock investigators. Jäntti T, et al. Among authors: tolppanen h. Ann Intensive Care. 2021 Feb 5;11(1):25. doi: 10.1186/s13613-021-00814-8. Ann Intensive Care. 2021. PMID: 33547528 Free PMC article.
Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Di Somma S, Tolppanen H, Zeymer U, Thiele H, Nieminen MS, Mebazaa A; CardShock Study Investigators; GREAT network. Harjola VP, et al. Among authors: tolppanen h. Eur J Heart Fail. 2015 May;17(5):501-9. doi: 10.1002/ejhf.260. Epub 2015 Mar 28. Eur J Heart Fail. 2015. PMID: 25820680 Free article.
Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study.
Hongisto M, Lassus J, Tarvasmäki T, Sionis A, Sans-Rosello J, Tolppanen H, Kataja A, Jäntti T, Sabell T, Lindholm MG, Banaszewski M, Silva Cardoso J, Parissis J, Di Somma S, Carubelli V, Jurkko R, Masip J, Harjola VP; CardShock Study Investigators and the GREAT Network. Hongisto M, et al. Among authors: tolppanen h. ESC Heart Fail. 2021 Apr;8(2):1398-1407. doi: 10.1002/ehf2.13224. Epub 2021 Jan 31. ESC Heart Fail. 2021. PMID: 33522124 Free PMC article.
Biomarkers in cardiogenic shock.
Lassus J, Tarvasmäki T, Tolppanen H. Lassus J, et al. Among authors: tolppanen h. Adv Clin Chem. 2022;109:31-73. doi: 10.1016/bs.acc.2022.03.002. Epub 2022 Apr 25. Adv Clin Chem. 2022. PMID: 35953128 Review.
Prevalence, Temporal Evolution, and Impact on Survival of Ventricular Conduction Blocks in Patients With Acute Coronary Syndrome and Cardiogenic Shock.
Tolppanen H, Javanainen T, Sans-Rosello J, Parenica J, Nieminen T, Pavlusova M, Masip J, Köber L, Banaszewski M, Sionis A, Spinar J, Harjola VP, Jurkko R, Lassus J; CardShock study investigators and for the GREAT Network. Tolppanen H, et al. Am J Cardiol. 2018 Jul 15;122(2):199-205. doi: 10.1016/j.amjcard.2018.04.008. Epub 2018 Apr 20. Am J Cardiol. 2018. PMID: 29778237
Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.
Jäntti T, Tarvasmäki T, Harjola VP, Parissis J, Pulkki K, Javanainen T, Tolppanen H, Jurkko R, Hongisto M, Kataja A, Sionis A, Silva-Cardoso J, Banaszewski M, Spinar J, Mebazaa A, Lassus J; CardShock investigators. Jäntti T, et al. Among authors: tolppanen h. PLoS One. 2019 May 16;14(5):e0217006. doi: 10.1371/journal.pone.0217006. eCollection 2019. PLoS One. 2019. PMID: 31095609 Free PMC article.
38 results